We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Alltracel PH. | LSE:AP. | London | Ordinary Share | IE0030515666 | ORD EUR0.0125 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 13.82 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:2981D
Alltracel Pharmaceuticals Plc
04 September 2007
Alltracel Pharmaceuticals plc
Notice of Interim Results
Tuesday, September 4th 2007: Dublin, Ireland and London, UK, Alltracel
Pharmaceuticals Plc., ("Alltracel", or "the Company"), (AIM:AP.L), the medical
technology company focused on the Woundcare, Oralcare and Cardiovascular Health
markets, today confirms it will announce its interim results for the six months
ended 30 June 2007 on Tuesday, 11 September 2007.
Enquiries:
Financial Dynamics 020 7831 3113
Mo Noonan
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORBRGDCGBGGGRS
1 Year Alltracel Pharmaceuticals Chart |
1 Month Alltracel Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
